Therapy of Alzheimer's Disease With Neurofeedback
Neurofeedback and Follow-up With Real-time fMRI to Investigate Cognitive Function in Patients of Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD)
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The project aims to investigate in patients of Alzheimer's disease in a prodromal state (early state of the disease) compared to healthy subjects whether neurofeedback training with functional MRI (fMRI) can improve cognitive ability. It is of interest if voluntary modulation of brain activation with real-time (rt) fMRI as a novel method affects cognitive ability, as well as functional and structural measures of the brain. Over the course of the study subjects will learn a real-world footpath. During neurofeedback training subjects are then asked to recall this footpath while simultaneously trying to modulate their own brain activation based on feedback. Feedback is given about the parahippocampal gyrus - a region of the brain associated with episodic and visuo-spatial memory, which is known to be affected early by Alzheimer's disease pathology. Before and after the training cognitive ability is assessed using neuropsychological tests mainly measuring numerous domains of memory. The investigators hypothesise that the training leads to an improvement of the trained cognitive domain, but also induces changes in brain structure and function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2016
CompletedFirst Submitted
Initial submission to the registry
February 23, 2017
CompletedFirst Posted
Study publicly available on registry
March 6, 2017
CompletedMarch 6, 2017
February 1, 2017
3.4 years
February 23, 2017
February 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual and Verbal Memory Test (VVM)
Neuropsychological assessment including visuo-spatial memory
2.5 weeks
Secondary Outcomes (8)
Montreal Cognitive Assessment (MoCA)
2.5 weeks
Wechsler Memory Scale Revised (WMS-R)
2.5 weeks
Trail Making Test (TMT)
2.5 weeks
Visual Patterns Test (VPT)
2.5 weeks
Parahippocampal activation
2.5 weeks
- +3 more secondary outcomes
Study Arms (3)
Healthy elderly experimental group
EXPERIMENTALFeedback of the parahippocampal gyrus using rtfMRI neurofeedback training (using 3T MRI).
Patient group
EXPERIMENTALFeedback of the parahippocampal gyrus using rtfMRI neurofeedback training (using 3T MRI).
Healthy elderly sham-feedback group
SHAM COMPARATORFeedback of the postcentral gyrus using rtfMRI neurofeedback training (using 3T MRI).
Interventions
Information about the state of brain activation was given to subjects. That information was visualised as a thermometer bar. Subjects tried to modulate that activation while performing a mental imagery task.
A 3T Siemens MRI scanner was used to implement rtfMRI neurofeedback training.
Eligibility Criteria
You may qualify if:
- Native speakers of German
- Naive to neurofeedback experiments
- Ability to provide written informed consent
You may not qualify if:
- Metallic implants (MR-safety)
- Neurological/psychiatric disease (except Alzheimer's disease in the patient group)
- Use of psychoactive medication (expect medication for Alzheimer's disease)
- Familiarity with the study site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Aachenlead
- Alzheimer Forschung Initiative e.V.collaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathrin Reetz, Prof. Dr.
University Hospital, Aachen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Healthy subjects in the sham feedback condition were not aware of their group membership, but were debriefed at the end of the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Memory Clinic and/or Principal Investigator
Study Record Dates
First Submitted
February 23, 2017
First Posted
March 6, 2017
Study Start
January 30, 2013
Primary Completion
June 30, 2016
Study Completion
June 30, 2016
Last Updated
March 6, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share